Marinomed Biotech AG 2023 Company Presentation

Loading viewer...

investor_presentation

Format: PDF investor_presentation

Marinomed Biotech AG is an Austrian biopharmaceutical company listed on the Vienna Stock Exchange, operating across virology and immunology segments. The company develops OTC products including Carragelose and Marinosolv, plus proprietary solubilization technology partnerships. Key milestones include its 2019 IPO, 2021 Solv4U launch, and 2022 partnership with Procter & Gamble.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Marinomed Biotech AG

View all →

Marinomed Biotech AG Carragelose Strategic Options 2023

conference

8 Pages

Similar investor_presentations from other companies

Browse all →

Hologic Investor Presentation May 2023

investor_presentation

38 Pages

Hologic, Inc.

Tacoma Power 2017 Investor Forum Overview

investor_presentation